Tag
A standing ovation greeted the full results of Daraxonrasib, a targeted therapy for pancreatic cancer, marking a major breakthrough. The researcher expresses inspiration that nothing is undruggable anymore.
Daraxonrasib received a standing ovation at ASCO as Revolution Medicines' breakthrough against pancreatic cancer, celebrated by over 40,000 oncologists, entrepreneurs, investors, and patient advocates.
Derek Thompson highlights recent medical breakthroughs including an effective GLP-1 drug from Eli Lilly and a promising new pancreatic cancer drug from Revolution Medicines.
A clinical trial found that the daily pill daraxonrasib doubles survival time for patients with pancreatic cancer, offering a significant breakthrough in treatment with fewer side effects compared to chemotherapy.
A new AI model (REDMOD) can detect pancreatic cancer up to three years earlier than human doctors by analyzing CT scans for subtle irregularities, potentially improving early diagnosis and survival rates.